Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 75
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
FASEB J ; 38(4): e23470, 2024 Feb 29.
Artículo en Inglés | MEDLINE | ID: mdl-38354035

RESUMEN

Vascular calcification is a major risk factor for cardiovascular disease mortality, with a significant prevalence in chronic kidney disease (CKD). Pharmacological inhibition of histone acetyltransferase has been proven to protect against from vascular calcification. However, the role of Histone Deacetylase 2 (HDAC2) and molecular mechanisms in vascular calcification of CKD remains unknown. An in vivo model of CKD was established using mouse fed with a high adenine and phosphate diet, and an in vitro model was produced using human aortic vascular smooth muscle cells (VSMCs) stimulated with ß-glycerophosphate (ß-GP). HDAC2 expression was found to be reduced in medial artery of CKD mice and ß-GP-induced VSMCs. Overexpression of HDAC2 attenuated OPN and OCN upregulation, α-SMA and SM22α downregulation, and calcium deposition in aortas of CKD. The in vitro results also demonstrated that ß-GP-induced osteogenic differentiation was inhibited by HDAC2. Furthermore, we found that HDAC2 overexpression caused an increase in LC3II/I, a decrease in p62, and an induction of autophagic flux. Inhibition of autophagy using its specific inhibitor 3-MA blocked HDAC2's protective effect on osteogenic differentiation in ß-GP-treated VSMCs. Taken together, these results suggest that HDAC2 may protect against vascular calcification by the activation of autophagy, laying out a novel insight for the molecular mechanism in vascular calcification of CKD.


Asunto(s)
Glicerofosfatos , Insuficiencia Renal Crónica , Calcificación Vascular , Humanos , Animales , Ratones , Histona Desacetilasa 2/genética , Osteogénesis , Autofagia
2.
Sensors (Basel) ; 24(4)2024 Feb 11.
Artículo en Inglés | MEDLINE | ID: mdl-38400346

RESUMEN

The performance of the capacitive gap-sensing system plays a critical role in a satellite-based gravity gradiometer that is developed using an electrostatic accelerometer. The capacitive sensing gain mainly depends on the stabilized injection bias amplitude, the gain of the transformer bridge, and the trans-impedance amplifier. Previous studies have indicated that amplitude noise is the main factor influencing the noise of capacitive displacement detection. Analyzing the capacitive gap-sensing system indicates that the amplitude, frequency, phase, and broadband noises of the stabilized injection bias have varying levels of influence on the performance of the detection system. This paper establishes a model to clarify the mentioned effects. The validation of the sub-tests demonstrates that the analysis and evaluation results of various noise coefficients are highly consistent with the model's predicted outcomes.

3.
Environ Res ; 214(Pt 2): 113997, 2022 11.
Artículo en Inglés | MEDLINE | ID: mdl-35934142

RESUMEN

Biogas slurry (BS) and hydrothermal carbonization aqueous products (HAP), which are rich in nitrogen (N) and dissolved organic matter (DOM), can be used as organic fertilizer to substitute inorganic N fertilizer. To evaluate the effects of co-application of BS and HAP on the ammonia (NH3) volatilization and soil DOM content in wheat growth season, we compared six treatments that substituting 50%, 75%, and 100% of urea-N with BS plus HAP at low (L) or high (H) ratio, named BCL50, BCL75, BCL100, BCH50, BCH75, BCH100, respectively. Meanwhile, urea alone treatment was set as the control (CKU). The results showed that both BCL and BCH treatments significantly mitigate the NH3 volatilizations by 9.1%-45.6% in comparison with CKU (P < 0.05), whose effects were correlated with soil NH4+-N content. In addition, the decrease in soil urease activity contributed to the lower NH3 volatilization following application of BS plus HAP. Notably, BS plus HAP applications increased the microbial byproduct- and humic acid-like substances in soil by 9.9%-74.5% and 100.7%-451.9%, respectively. Consequently, BS and HAP amended treatments significantly increased soil humification index and DOM content by 13.7%-41.2% and 38.4%-158.7%, respectively (P < 0.05). This study suggested that BS and HAP could be co-applied into agricultural soil as a potential alternative of inorganic fertilizer N, which can decrease NH3 loss but increase soil fertility.


Asunto(s)
Fertilizantes , Suelo , Agricultura/métodos , Amoníaco/análisis , Biocombustibles , Fertilizantes/análisis , Nitrógeno/análisis , Triticum , Urea , Volatilización
4.
Zhongguo Zhong Yao Za Zhi ; 47(5): 1153-1160, 2022 Mar.
Artículo en Zh | MEDLINE | ID: mdl-35343139

RESUMEN

Chinese medicine undergoes complex chemical changes during processing and identifying these changes is the key to the processing mechanism. In the past 20 years of the 21 st century, research on the chemical changes in Chinese medicine after processing has focused the changes in the biopharmaceutical process in addition to the variation during processing. With the surging of information technologies, various identification technologies(instrumental analysis techniques, molecular biological techniques, data mining techniques, and biotransformation techniques) have developed rapidly and been widely applied to the research on processing mechanism. Thus, based on the chemical changes in the processing and biopharmaceutical process, the author suggested a research tactic of multimodal identification as the core by reorganizing key technologies for chemical identification from studies of the processing mechanism of Chinese me-dicine, aiming at establishing an interdisciplinary multi-dimensional research model for the processing mechanism of Chinese medicine.


Asunto(s)
Medicamentos Herbarios Chinos , Medicina Tradicional China , Medicamentos Herbarios Chinos/química , Tecnología
5.
Zhongguo Zhong Yao Za Zhi ; 47(5): 1170-1176, 2022 Mar.
Artículo en Zh | MEDLINE | ID: mdl-35343141

RESUMEN

Clarifying the mechanisms of Chinese medicinal processing is pivotal to the modernization of Chinese medicine. Research on Chinese medicinal processing gives priority to the mechanisms of the processing in enhancing efficacy, reducing toxicity, and repurposing medicinals. During the past 20 years, scholars have carried out in-depth studies on the mechanisms of Chinese medicinal processing via modern system biology. They mainly focused on the changes of medicinal properties and efficacy caused by processing using techniques of modern pharmacology and molecular biology, spectrum-efficacy correlation, and biophoton emission. However, these techniques fail to reflect the holistic view of traditional Chinese medicine. With the introduction of system biology, multi-omics techno-logies(genomics, transcriptomics, proteomics, and metabolomics) have surged, which have been applied to the research on the mec-hanisms of Chinese medicinal processing. These multi-omics technologies have advantages in the research on holism. This study aims to summarize the research techniques and approaches in system biology for mechanisms of Chinese medicinal processing in the past 20 years and analyze the limitations and advantages of them. It is concluded that the multi-omics techniques of system biology can reconstruct the mechanisms of Chinese medicinal processing. This study provides a new direction for further research on the mechanisms of Chinese medicinal processing.


Asunto(s)
Medicina Tradicional China , Metabolómica , China , Genómica , Metabolómica/métodos , Proteómica
6.
Rheumatology (Oxford) ; 60(11): 5089-5097, 2021 11 03.
Artículo en Inglés | MEDLINE | ID: mdl-33693494

RESUMEN

OBJECTIVE: To evaluate the efficacy and safety of SHR4640, a highly selective urate transporter 1 inhibitor, in Chinese subjects with hyperuricaemia. METHODS: This was a randomized double-blind dose-ranging phase II study. Subjects whose serum uric acid (sUA) levels were ≥480 µmol/l with gout, ≥480 µmol/l without gout but with comorbidities, or ≥540 µmol/l were enrolled. Subjects were randomly assigned (1:1:1:1:1) to receive once daily 2.5 mg, 5 mg, 10 mg of SHR4640, 50 mg of benzbromarone or placebo, respectively. The primary end point was the proportion of subjects who achieved target sUA level of ≤360 µmol/l at week 5. RESULTS: 99.5% of subjects (n = 197) were male and 95.9% of subjects had gout history. The proportions of subjects who achieved target sUA at week 5 were 32.5%, 72.5% and 61.5% in the 5 mg, 10 mg SHR4640 and benzbromarone groups, respectively, significantly higher than the placebo group (0%; P < 0.05 for 5 mg and 10 mg SHR4640 group). The sUA was reduced by 32.7%, 46.8% and 41.8% at week 5 with 5 mg, 10 mg SHR4640 and benzbromarone, respectively, vs placebo (5.9%; P < 0.001 for each comparison). The incidences of gout flares requiring intervention were similar among all groups. Occurrences of treatment-emergent adverse events (TEAEs) were comparable across all groups, and serious TEAEs were not reported. CONCLUSIONS: The present study indicated a superior sUA-lowering effect and well tolerated safety profile after 5-week treatment with once-daily 5 mg/10 mg of SHR4640 as compared with placebo in Chinese subjects with hyperuricaemia. TRIAL REGISTRATION: ClinicalTrials.gov number, NCT03185793.


Asunto(s)
Ciclobutanos/uso terapéutico , Hiperuricemia/tratamiento farmacológico , Transportadores de Anión Orgánico/antagonistas & inhibidores , Proteínas de Transporte de Catión Orgánico/antagonistas & inhibidores , Quinolinas/uso terapéutico , Adolescente , Adulto , Anciano , Ciclobutanos/farmacología , Método Doble Ciego , Femenino , Humanos , Enfermedades Renales/inducido químicamente , Masculino , Persona de Mediana Edad , Quinolinas/farmacología , Resultado del Tratamiento , Adulto Joven
7.
Appl Opt ; 60(1): 194-200, 2021 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-33362090

RESUMEN

In this work, we present an accurate polarization reconstruction method based on the coherence demodulation technique, which is different from the previous windowing method operating in the optical path difference domain. The proposed method uses a signal multiplier and a low-pass filter to reconstruct Stokes parameters without performing any Fourier transform. Because this method does not require a Fourier transform, the Stokes reconstruction could be finished in the spectral domain. For calibrating the waveplate phase error, coherence demodulation allows for establishing an analytical model to describe the influence of waveplate imperfections on the polarization measurement process. The phase error will result in a channel shift and Fourier broadening, both of which cause serious errors during Stokes reconstruction. With the model, a method based on a linear polarizer was proposed for calibrating the phase deviation of waveplate. After that, the accurate reconstruction of polarization parameters could be achieved. An experiment was performed to check the ability of the proposed method. The experimental result showed that it has the same excellent performance of reconstructing Stokes parameters using the traditional windowing method. Finally, a series of simulations was carried out to verify the robustness of this method, which showed that the reconstruction technique is robust to misalignment and additional noise.

8.
Sensors (Basel) ; 21(22)2021 Nov 22.
Artículo en Inglés | MEDLINE | ID: mdl-34833829

RESUMEN

In order to verify the performance of a graphene-based space radiation detection sensor, the radiation detection principle based on two-dimensional graphene material was analyzed according to the band structure and electric field effect of graphene. The method of space radiation detection based on graphene was studied and then a new type of space radiation sensor samples with small volume, high resolution, and radiation-resistance was formed. Using protons and electrons, the electrical performance of GFET radiation sensor was verified. The designed graphene space radiation detection sensor is expected to be applied in the radiation environment monitoring of the space station and the moon, and can also achieve technological breakthroughs in pulsar navigation and other fields.

9.
Opt Express ; 28(9): 13625-13637, 2020 Apr 27.
Artículo en Inglés | MEDLINE | ID: mdl-32403833

RESUMEN

Channeled Mueller matrix spectropolarimeters (CMMSPs) have gained increasing popularity in recent years due to no moving parts. However, in order to obtain more accurate measurements, thorough studies on the influence and correction of their systematic errors are still needed. This paper presents a novel perspective for CMMSPs based on a signal processing technique, and propose a coherence demodulation method to extract channel signals in the modulated intensity. From theoretical analysis, the influence of phase deviation resulting from the imperfection of retarders is pinpointed. Meanwhile, the mechanism of phase deviation is described in theory and visually displayed by simulation. To mitigate the interference of retarder phase deviation, this work proposes a way for correction utilizing a vacuum and polarizer as determinant samples. Noticeably, the phase deviations are treated as a whole and represented by polynomials during correction. The reverse process of error mechanism is used to correct the influence. Finally, this means is proved by a series of simulation validations with a detector noise of 30 dB and retarder misalignment errors of 0.5°.

10.
Opt Lett ; 45(3): 776-779, 2020 Feb 01.
Artículo en Inglés | MEDLINE | ID: mdl-32004309

RESUMEN

In this Letter, we utilize an acoustic-optic frequency shifter in a feedforward manner for automatic interpolation of dual-comb spectroscopy, where frequency tuning can be achieved at 5.45 THz/s with the step size precisely locked to the line spacing (54.5 MHz) of a referenced optical comb without complicated electronics or control programs. Our dual-comb spectrometer involves two near-infrared electro-optic combs at 25 GHz line spacings, nonlinearly converted into the mid-infrared region, revealing fundamental absorption lines of methane gas at 54.5 MHz resolution within a spectral range from 88.04 to 89.04 THz. The method and the system may be useful in many applications, including gas sensing.

11.
J Cell Physiol ; 234(12): 22857-22873, 2019 12.
Artículo en Inglés | MEDLINE | ID: mdl-31127625

RESUMEN

To simulate clinical features in human chronic kidney disease (CKD), SD rats were subjected to 5/6 nephrectomy in this study. We found that periostin gene was upregulated in the remnant kidneys using Agilent gene microarrays, and further explored its role via in vivo and in vitro experiments. Intrarenal renin-angiotensin system (RAS) was activated in 5/6 nephrectomized rats and partly deactivated by injection of adenoviruses encoding short hairpin RNA against periostin (sh-periostin). Renal fibrosis in nephrectomized rats and profibrotic transforming growth factor-ß-induced epithelial-mesenchymal transition (EMT) and ERK1/2 activation in NRK-52E cells were suppressed by sh-periostin. Moreover, knockdown of periostin decreased the generation of Interleukin 6 (IL6) and tumor necrosis factor-α (TNF-α) and accelerated p62 degradation in the remnant kidneys. Both HK-2 cells treated with recombinant periostin and NRK-52E cells infected with adenoviruses expressing periostin produced more IL6 and TNF-α than control cells and displayed impaired autophagy as evidenced by inhibition of LC3II to LC3I conversion, Beclin 1 expression, and p62 degradation. By treating cells with rapamycin, an inhibitor of mamalian target of rapamycin known to activate autophagy, we noted that periostin-induced inflammation was inhibited. Additionally, HK-2 cells transfected with periostin overexpression plasmid generated more CCL2 and CXCL10, two important chemotactic factors, than untransfected cells. Conditioned medium from HK-2 cells overexpressing periostin augmented chemotaxis of THP-1 macrophages. Collectively, our work demonstrates that knockdown of periostin attenuates 5/6 nephrectomy-induced intrarenal RAS activation, fibrosis, and inflammation in rats. These findings advance our understanding of periostin's role in CKD induced by nephron loss.


Asunto(s)
Moléculas de Adhesión Celular/metabolismo , Riñón/metabolismo , Nefrectomía , Nefritis/metabolismo , Interferencia de ARN , Insuficiencia Renal Crónica/metabolismo , Sistema Renina-Angiotensina , Animales , Autofagia , Moléculas de Adhesión Celular/genética , Quimiotaxis de Leucocito , Citocinas/metabolismo , Modelos Animales de Enfermedad , Transición Epitelial-Mesenquimal , Fibrosis , Humanos , Mediadores de Inflamación/metabolismo , Riñón/patología , Nefritis/genética , Nefritis/patología , Nefritis/prevención & control , Ratas Sprague-Dawley , Insuficiencia Renal Crónica/genética , Insuficiencia Renal Crónica/patología , Insuficiencia Renal Crónica/prevención & control , Sistema Renina-Angiotensina/genética , Transducción de Señal , Células THP-1
12.
BMC Nephrol ; 20(1): 455, 2019 12 09.
Artículo en Inglés | MEDLINE | ID: mdl-31818266

RESUMEN

BACKGROUND: The timing of when to initiate dialysis for progressive chronic kidney disease (CKD) patients has not been well established. There has been a strong trend for early dialysis initiation for these patients over the past decades. However, the perceived survival advantage of early dialysis has been questioned by a series of recent observational studies. The only randomized controlled trial (RCT) research on this issue found the all-cause mortality, comorbidities, and quality of life showed no difference between early and late dialysis starters. To better understand optimal timing for dialysis initiation, our research will evaluate the efficacy and safety of deferred dialysis initiation in a large Chinese population. METHODS: The trial adopts a multicenter, cluster randomized, single-blind (outcomes assessor), and endpoint-driven design. Eligible participants are 18-80 years old, in stable CKD stages 4-5 (eGFR > 7 ml/min /1.73 m2), and with good heart function (NYHA grade I or II). Participants will be randomized into a routine or deferred dialysis group. The reference eGFR at initiating dialysis for asymptomatic patients is 7 ml/min /1.73 m2 (routine dialysis group) and 5 ml/min/1.73 m2 or less (deferred dialysis group) in each group. The primary endpoint will be the difference of all-cause mortality and acute nonfatal cerebro-cardiovascular events between the two groups. The secondary outcomes include hospitalization rate and other safety indices. The primary and secondary outcomes will be analyzed by appropriate statistical methods. DISCUSSION: This study protocol represents a large, cluster randomized study evaluating deferred and routine dialysis intervention for an advanced CKD population. The reference eGFR to initiate dialysis for both treatment groups is targeted at less than 7 ml/min/1.73m2. With this design, we aim to eliminate lead-time and survivor bias and avoid selection bias and confounding factors. We acknowledge that the study has limitations. Even so, given the low-targeted eGFR values of both arms, this study still has potential economic, health, and scientific implications. This research is unique in that such a low targeted eGFR value has never been studied in a clinical trial. TRIAL REGISTRATION: The trial has been approved by ClinicalTrials.gov (Trial registration ID NCT02423655). The date of registration was April 22, 2015.


Asunto(s)
Vigilancia de la Población , Diálisis Renal/normas , Insuficiencia Renal Crónica/epidemiología , Insuficiencia Renal Crónica/terapia , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , China/epidemiología , Análisis por Conglomerados , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Vigilancia de la Población/métodos , Estudios Prospectivos , Diálisis Renal/métodos , Insuficiencia Renal Crónica/diagnóstico , Método Simple Ciego , Adulto Joven
13.
Ecotoxicol Environ Saf ; 176: 279-287, 2019 Jul 30.
Artículo en Inglés | MEDLINE | ID: mdl-30947031

RESUMEN

2,2',4,4'-tetrabrominated diphenyl ether (BDE-47) and 2,2',4,4',5-pentabromodiphenyl ether (BDE-99) are two typical polybrominated diphenyl ethers (PBDEs), and studies have proven that these PBDs can disrupt the behaviors and physical function of aquatic organisms. However, little is known about the compositional impacts of BDE-47/BDE-99 compound pollution on the feeding behavior of Daphnia magna. In this study, a response surface methodology (RSM) was introduced into the combined toxicity assessment of BDE-47 and BDE-99 on the feeding depression of D. magna. Low concentrations of BDE-47 (9.2 µg/L) and BDE-99 (5.4 µg/L) had no effect on the feeding behavior of D. magna; nevertheless, the feeding depression was strengthened, and a concentration-dependent effect was observed with increasing concentrations of BDE-47 and BDE-99. The results of RSM indicated that the mixture of BDE-47 and BDE-99 can enhance their toxicity on the feeding behavior of D. magna. Moreover, real-time PCR (qPCR) analysis showed that the down-regulation of α-amylase (AMS) appeared in most of the exposed D. magna. However, there were significant different in the gene expression of trypsin, superoxide dismutase (SOD) and catalase (CAT) between the exposure and control groups. The change in the enzyme activity of AMS, trypsin, SOD and CAT implied that BDE-47 and BDE-99 cause damage to the digestive and antioxidative systems of D. magna. Correlation analysis indicated that a significant positive correlation existed between the gene expression and enzyme activity of SOD and CAT. Our results contribute to the understanding of toxicity caused by BDE-47/BDE-99 compound pollution in D. magna and help to improve traditional toxicity assessment methods for aquatic environments.


Asunto(s)
Antioxidantes/metabolismo , Daphnia/efectos de los fármacos , Digestión/efectos de los fármacos , Conducta Alimentaria/efectos de los fármacos , Éteres Difenilos Halogenados/toxicidad , Contaminantes Químicos del Agua/toxicidad , Animales , Catalasa/genética , Daphnia/enzimología , Relación Dosis-Respuesta a Droga , Expresión Génica/efectos de los fármacos , Superóxido Dismutasa/genética
14.
Eur J Mass Spectrom (Chichester) ; 24(2): 206-213, 2018 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-29130790

RESUMEN

With the rapid development of space technology in China, it is urgent to use mass spectrometer to detect the space environment. In this work, a space miniature magnetic sector mass spectrometer is evaluated, which consists of three subsystems: (1) physical unit, (2) electric control unit, (3) and high voltage power. It has 90° magnetic sector-field analyzer with double trajectory, in which a trajectory measurement range is from 1 to 12 amu, the other range is from 6 to 90 amu.The mass spectrometer has two work models, one is used to measure space neutral gas when the filament of mass spectrometer ion source turned on, the other is used to measure space charged ions when the filament turned off. The absolute resolution of this device is less than 1 amu, the minimum detectable ion current is about 10-13 A, and the sensitivity is 10-6 A/Pa (N2). Its overall size is 170 mm × 165 mm × 170 mm, its weight is 4.5 kg, and its power consumption is 18 W. A series of environmental adaptability tests, including high and low temperature cycle, shock, vibration, thermal vacuum cycle, were carried out on the ground before launching, and sensitivity and peak position were also calibrated on the ground. In November 2012, the mass spectrometer was carried by an experimental satellite to 499 km sun synchronization and is still working right now. It successfully detected the atmosphere compositions both in the satellite orbit and gas-emitted from satellite, including O, He, 12CO2, 13CO2, H2, N2, O2, H2O, and so on.

15.
Eur J Mass Spectrom (Chichester) ; 24(4): 322-329, 2018 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-29759016

RESUMEN

A miniaturized linear ion trap mass spectrometer with continuous atmospheric pressure interface has been built in our lab. Significant extension in mass range and reduction in power consumption have been realized by the supplemental alternating current frequency scan mode. However, relatively poor sensitivity has been witnessed, which is directly dominated by the detection efficiency of the ion detector. Theoretical analysis has been implemented to find ways to improve the detection efficiency. The results show that enhanced sensitivity can be obtained by applying a direct current voltage on the pair of electrodes in eject direction. Experiments show that the sensitivity has been improved by more than one time due to the application of direct current voltage. With this design, this homemade miniature linear ion trap mass spectrometer can be used to analyze more rarefied samples, especially to on-site chemical analysis and space application.

16.
Cell Physiol Biochem ; 41(2): 689-700, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28214836

RESUMEN

BACKGROUND/AIMS: Hepatitis B virus (HBV)-associated glomerulonephritis (HBV-GN) is characterized by a reduced number of podocytes due to apoptosis and shedding from the basement membrane. However, the pathological mechanism of HBV-GN is unclear. We previously showed that hepatitis B virus X protein (HBx) promotes apoptosis in tubular epithelial cells. In this study, we transfected podocytes with HBx and examined the effects on adhesion and apoptosis of these cells. METHODS: Podocytes were transfected with pc-DNA3.1 (+)-HBx. One control group was not transfected and another control group was transfected with empty plasmids. Podocyte adhesion was assessed by a fluorescence assay, apoptosis was measured by flow cytometry and fluorescence microscopy, and expression of α3ß1 integrin was determined by western blotting and the reverse transcription polymerase chain reaction (RT-PCR). Activity of caspase-8 was measured by a spectrophotometric assay. RESULTS: Relative to controls, podocytes with pc-DNA3.1(+)-HBx had reduced cell adhesion, increased apoptosis, reduced expression of α3ß1 integrin, and increased caspase-8 activity. ß1 integrin blockage reduced podocyte adhesion, but increased apoptosis and caspase-8 activity. Treatment of transfected podocytes with a caspase-8 inhibitor (Z-IETD-FMK) had no effect on the HBx-mediated integrin downregulation and reduced podocyte adhesion, suggesting that α3ß1 integrin downregulaton is sufficient to alter cell adhesion. CONCLUSIONS: Our in vitro results indicate that HBx reduced podocyte adhesion and expression of α3ß1 integrin, and increased apoptosis. Moreover, HBx-mediated downregulation of α3ß1 integrin expression is sufficient to reduce podocyte adhesion. HBx-induced apoptosis of podocytes may contribute to HBV-GN.


Asunto(s)
Transactivadores/metabolismo , Células A549 , Animales , Anticuerpos/inmunología , Apoptosis , Caspasa 8/análisis , Caspasa 8/química , Caspasa 8/metabolismo , Inhibidores de Caspasas/farmacología , Adhesión Celular/efectos de los fármacos , Línea Celular , Regulación hacia Abajo , Humanos , Integrina alfa3beta1/genética , Integrina alfa3beta1/inmunología , Integrina alfa3beta1/metabolismo , Ratones , Oligopéptidos/farmacología , Plásmidos/metabolismo , Espectrofotometría , Transactivadores/genética , Proteínas Reguladoras y Accesorias Virales
17.
Cell Physiol Biochem ; 39(4): 1433-43, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27606894

RESUMEN

BACKGROUND/AIMS: The hepatitis B virus X protein (HBx) contributes to HBV-induced injury of renal tubular cells and induces apoptosis via Fas/FasL up-regulation. However, the mechanism of Fas/FasL activation is unknown. Recent studies indicated that HBx induction of apoptosis in hepatic cells depends on activating the MLK3-MKK7-JNKs signaling module, which then up-regulates FasL expression. In this study, we used NRK-52E cells transfected an HBx expression vector to examine the role of the MLK3-MKK7-JNKs signaling pathway on HBx-induced renal tubular cell injury. METHODS: NRK-52E cells were transfected with pc-DNA3.1(+)-HBx to establish an HBx over-expression model, and with pc-DNA3.1(+)-HBx and pSilencer3.1-shHBx to establish an HBx low expression model. One control group was not transfected and another control group was transfected with an empty plasmid. Cell proliferation was determined by the formazan dye method (Cell Counting Kit-8) and apoptosis was measured by flow cytometry and fluorescence microscopy. Western blotting was used to measure the expression of Fas, FasL, and MLK3-MKK7-JNKs signaling pathway-related proteins. The activity of caspase-8 was measured by spectrophotometry. RESULTS: Transfection of NRK-52E cells with pc-DNA3.1(+)-HBx inhibited cell proliferation and increased apoptosis and caspase-8 activity. The expression of Fas, FasL, and MLK3-MKK7-JNKs signaling pathway-related proteins were also greater in the pc-DNA3.1(+)-HBx group, but lower in RNAi group. Furthermore, the activity of MLK3-MKK7-JNKs signaling pathway, expression of Fas/FasL, and apoptosis were significantly lower in the pc-DNA3.1(+)-HBx group when treated with K252a, a known inhibitor of MLK3. CONCLUSIONS: Our results show that HBx induces apoptosis in NRK-52E cells and activates Fas/FasL via the MLK3-MKK7-JNK3-c-Jun signaling pathway.


Asunto(s)
Células Epiteliales/efectos de los fármacos , Proteína Ligando Fas/agonistas , Virus de la Hepatitis B/química , Transducción de Señal/genética , Transactivadores/farmacología , Receptor fas/agonistas , Animales , Apoptosis/efectos de los fármacos , Carbazoles/farmacología , Caspasa 8/genética , Caspasa 8/metabolismo , Línea Celular , Proliferación Celular/efectos de los fármacos , Células Epiteliales/citología , Células Epiteliales/metabolismo , Proteína Ligando Fas/genética , Proteína Ligando Fas/metabolismo , Regulación de la Expresión Génica , Alcaloides Indólicos/farmacología , Túbulos Renales/citología , Túbulos Renales/efectos de los fármacos , Túbulos Renales/metabolismo , MAP Quinasa Quinasa 7/genética , MAP Quinasa Quinasa 7/metabolismo , Quinasas Quinasa Quinasa PAM/genética , Quinasas Quinasa Quinasa PAM/metabolismo , Proteína Quinasa 10 Activada por Mitógenos/genética , Proteína Quinasa 10 Activada por Mitógenos/metabolismo , Plásmidos/química , Plásmidos/metabolismo , Ratas , Transactivadores/aislamiento & purificación , Transfección , Proteínas Reguladoras y Accesorias Virales , Receptor fas/genética , Receptor fas/metabolismo , Proteina Quinasa Quinasa Quinasa 11 Activada por Mitógeno
18.
J Surg Res ; 197(1): 145-54, 2015 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-25913488

RESUMEN

BACKGROUND: Tubular cell apoptosis plays a crucial role in different kinds of renal diseases. Epigallocatechin-3-gallate (EGCG), a polyphenol extracted from green tea, has been shown to inhibit renal fibrosis in unilateral ureteral obstruction (UUO) mice, but its role in preventing tubular cell apoptosis and the underlying signaling mechanisms still remains unclear. MATERIALS AND METHODS: Mice subjected to UUO were intraperitoneally administered EGCG (5 mg/kg) for 14 d. Normal rat kidney proximal tubular epithelial cell line NRK-52E was induced by transforming growth factor ß1 (TGF-ß1). Periodic acid-schiff and Masson's trichrome staining was used for histologic study. TUNEL, Hoechst staining, and flow cytometry analysis were used to measure the apoptotic status of tubular cells. Western blotting was used to determine the expression of apoptotic-associated proteins and mitogen-activated protein kinase pathway proteins. RESULTS: EGCG significantly attenuated tubular injury and renal tubulointerstitial fibrosis in the obstructed kidneys of UUO mice. In addition, EGCG prevented UUO and TGF-ß1-induced tubular apoptosis in a dose-dependent manner. In parallel, protein expression of B-clell lymphoma-2 (Bcl-2) was upregulated and protein expressions of Bcl-2 accosiated X protein (Bax), cleaved caspase 3, and cleaved poly ADP-ribose polymerase (PARP) were downregulated by EGCG. Furthermore, UUO and TGF-ß1-stimulated phosphorylation of mitogen-activated protein kinase was inhibited by EGCG. CONCLUSIONS: EGCG effectively reduces tubular cell apoptosis induced by UUO and may have potential as a clinical treatment in patients with chronic kidney disease.


Asunto(s)
Apoptosis/efectos de los fármacos , Catequina/análogos & derivados , Túbulos Renales/efectos de los fármacos , Sustancias Protectoras/farmacología , Obstrucción Ureteral/tratamiento farmacológico , Animales , Apoptosis/fisiología , Biomarcadores/metabolismo , Western Blotting , Catequina/farmacología , Catequina/uso terapéutico , Línea Celular , Citometría de Flujo , Etiquetado Corte-Fin in Situ , Túbulos Renales/metabolismo , Túbulos Renales/fisiopatología , Sistema de Señalización de MAP Quinasas/fisiología , Ratones , Sustancias Protectoras/uso terapéutico , Ratas , Obstrucción Ureteral/metabolismo , Obstrucción Ureteral/fisiopatología
19.
Clin Exp Pharmacol Physiol ; 42(6): 671-9, 2015 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-25867712

RESUMEN

Peritoneal dialysis (PD) is an effective treatment for patients with end-stage renal diseases, but long-term continuous PD causes peritoneal fibrosis (PF). This study aims to evaluate the anti-fibrotic effect of telmisartan on a rat model of PF and to investigate the underlying mechanisms. Five-sixths kidney nephrectomy and PD were used to establish the PF rat model. Glucose (2.5%) was used to establish an in vitro model in rat peritoneal mesothelial cells (PMC). Haematoxylin-eosin staining was used to examine the structural alterations. Masson's trichrome staining was used to observe the tissue fibrosis in peritoneal membrane of rats. Real-time polymerase chain reaction was used to measure messenger RNA expressions of profibrotic factors. Western blotting was used to determine protein expressions of profibrotic factors, peroxisome proliferator-activated receptor-γ, and mitogen-activated protein kinases (MAPK). Results demonstrated that administration of telmisartan dose-dependently attenuated the thickening of the peritoneal membrane and the fibrosis induced by long-term PD fluid exposure in rats. In addition, telmisartan treatment inhibited the upregulation of profibrotic factors induced by PD in the peritoneum of rats and by high-concentration glucose in PMC. Telmisartan was also effective in inhibiting PD and high-concentration, glucose-induced phosphorylation of MAPK in the peritoneum and PMC. Furthermore, peroxisome proliferator-activated receptor-γ (PPARγ) inhibitor GW9662 blocked these protective effects of telmisartan in PMC. The results suggest that telmisartan is effective in attenuating PD-induced PF, and this effect may be associated with the inhibition of profibrotic factor expression and MAPK phosphorylation via PPARγ activation.


Asunto(s)
Bloqueadores del Receptor Tipo 1 de Angiotensina II/uso terapéutico , Bencimidazoles/uso terapéutico , Benzoatos/uso terapéutico , PPAR gamma/metabolismo , Fibrosis Peritoneal/metabolismo , Fibrosis Peritoneal/prevención & control , Animales , Células Cultivadas , Relación Dosis-Respuesta a Droga , Masculino , PPAR gamma/antagonistas & inhibidores , Fibrosis Peritoneal/patología , Ratas , Ratas Sprague-Dawley , Telmisartán
20.
Am J Nephrol ; 39(1): 75-84, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24457259

RESUMEN

AIMS: The optimal time for mesenchymal stem cell (MSCs) transplantation remains an unresolved issue. We compared the effects of MSCs on a rat remnant kidney model. METHODS: Male Sprague-Dawley rats were randomly divided and treated with a corresponding reagent at 4, 8, 12 and 16 weeks, respectively. A remnant kidney model was established and MSCs were injected into rats. The migration of MSCs was then assessed by using cell-tracking experiments. Renal function and histological analyses were performed 4 weeks after MSC transplantation. Immunohistochemistry, Western blotting and real-time polymerase chain reaction were used to detect the TGF-ß1 and α-SMA levels. RESULTS: Four weeks after MSC injection, MSCs were found to migrate to the injured kidney. Significant histological damage improvement was observed after the treatment of MSCs at 4 and 8 weeks. The functional benefits of MSC treatment were observed in the 5/6 nephrectomy (Nx) + MSC group and the benefits were significantly higher at 4 and 8 weeks than at other time points (p < 0.05). Meanwhile, serum creatinine and urea levels as well as glomerular sclerosis and tubulointerstitial injury indexes were decreased at 4 and 8 weeks. Compared with the 5/6 Nx + PBS group, TGF-ß1 and α-SMA levels were decreased in the 5/6 Nx + MSC group. CONCLUSION: These data can be used to optimize the MSC transplantation time point as a therapeutic modality.


Asunto(s)
Trasplante de Riñón/métodos , Células Madre Mesenquimatosas/citología , Actinas/metabolismo , Animales , Movimiento Celular , Creatinina/sangre , Fibrosis/terapia , Tasa de Filtración Glomerular , Glomeruloesclerosis Focal y Segmentaria/sangre , Túbulos Renales/lesiones , Masculino , Ratas , Ratas Sprague-Dawley , Factores de Tiempo , Factor de Crecimiento Transformador beta/metabolismo , Urea/sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA